OA 05.07 Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC
Autor: | Cho, B.C., Obermannová, R., Bearz, A., Kim, D., Orlov, S., Borra, G., Kim, S., Postmus, P.E., Laurie, S., Park, K., Geater, S., Bettini, A.C., Osborne, K., Passos, V.Q., Chen, Z., Dziadziuszko, R. |
---|---|
Zdroj: | In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1757-S1757 |
Databáze: | ScienceDirect |
Externí odkaz: |